CALC CalciMedica Inc

Price (delayed)

$0.868

Market cap

$13.71M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.3

Enterprise value

$12.25M

?
Relative Growth: Rel. Growth: 20
Relative Strength: Rel. Strength: 16
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, ...

Highlights
The EPS has grown by 34% from the previous quarter and by 17% YoY
The debt has declined by 31% since the previous quarter and by 22% year-on-year
CALC's equity has dropped by 110% year-on-year but it has soared by 83% since the previous quarter
CALC's net income is up by 34% QoQ but it is down by 3.6% YoY
The quick ratio has plunged by 72% YoY and by 55% from the previous quarter

Key stats

What are the main financial stats of CALC

CALC stock price

How has the CalciMedica stock price performed over time
Intraday
2.09%
1 week
-0.23%
1 month
48.3%
1 year
-49.39%
YTD
-86.83%
QTD
60.74%

Financial performance

How have CalciMedica's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$22.24M
Net income
-$19.54M
Gross margin
N/A
Net margin
N/A
CALC's net income is up by 34% QoQ but it is down by 3.6% YoY
CALC's operating income is up by 11% year-on-year and by 3.8% since the previous quarter

Price vs fundamentals

How does CALC's price correlate with its fundamentals

Growth

What is CalciMedica's growth rate over time

Valuation

What is CalciMedica stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 34% from the previous quarter and by 17% YoY
CALC's equity has dropped by 110% year-on-year but it has soared by 83% since the previous quarter

Efficiency

How efficient is CalciMedica business performance
CalciMedica's return on assets has shrunk by 52% YoY but it has increased by 14% QoQ
The ROIC has grown by 12% from the previous quarter and by 6% YoY

Dividends

What is CALC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CALC.

Financial health

How did CalciMedica financials performed over time
The total assets is 11% smaller than the total liabilities
The quick ratio has plunged by 72% YoY and by 55% from the previous quarter
The company's current ratio has shrunk by 72% YoY and by 55% QoQ
CALC's equity has dropped by 110% year-on-year but it has soared by 83% since the previous quarter
The debt has declined by 31% since the previous quarter and by 22% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.